,date,symbol,reportedCurrency,fillingDate,acceptedDate,period,revenue,costOfRevenue,grossProfit,grossProfitRatio,researchAndDevelopmentExpenses,generalAndAdministrativeExpenses,sellingAndMarketingExpenses,otherExpenses,operatingExpenses,costAndExpenses,interestExpense,depreciationAndAmortization,ebitda,ebitdaratio,operatingIncome,operatingIncomeRatio,totalOtherIncomeExpensesNet,incomeBeforeTax,incomeBeforeTaxRatio,incomeTaxExpense,netIncome,netIncomeRatio,eps,epsdiluted,weightedAverageShsOut,weightedAverageShsOutDil,link,finalLink,timestamp,est_time,est_date
0,2019-12-31,BVXV,ILS,2019-12-31,2019-12-31,FY,0.0,0.0,0.0,0.0,68645000.0,9354000.0,0.0,0.0,78351000.0,78351000.0,14918000.0,352000.0,-77999000.0,0.0,-78351000.0,0.0,-15773000.0,-109194000.0,0.0,0.0,-109194000.0,0.0,-13.2,-13.2,8166293.0,8166293.0,,,1620589783,15:49:43,20210509
1,2018-12-31,BVXV,ILS,2019-04-30,2019-04-30,FY,0.0,0.0,0.0,0.0,71913000.0,5089000.0,0.0,0.0,77067000.0,77067000.0,13545000.0,65000.0,-77002000.0,0.0,-77067000.0,0.0,2836000.0,-87727000.0,0.0,0.0,-87727000.0,0.0,-13.6,-13.6,6535490.0,6535490.0,https://www.sec.gov/Archives/edgar/data/1611747/000121390019007348/f20f2018_biondvaxpharma.htm,https://www.sec.gov/Archives/edgar/data/1611747/000121390019007348/f20f2018_biondvaxpharma.htm,1620589783,15:49:43,20210509
2,2017-12-31,BVXV,ILS,2018-04-30,2018-04-30,FY,0.0,0.0,0.0,0.0,18777000.0,4749000.0,0.0,0.0,23656000.0,23656000.0,0.0,130000.0,-23526000.0,0.0,-23656000.0,0.0,-10913000.0,-34551000.0,0.0,0.0,-34551000.0,0.0,-6.8,-6.8,5025769.0,5025769.0,https://www.sec.gov/Archives/edgar/data/1611747/000121390018005179/f20f2017_biondvaxpharma.htm,https://www.sec.gov/Archives/edgar/data/1611747/000121390018005179/f20f2017_biondvaxpharma.htm,1620589783,15:49:43,20210509
3,2016-12-31,BVXV,ILS,2017-04-28,2017-04-28,FY,0.0,0.0,0.0,0.0,7794000.0,4058000.0,0.0,0.0,11900000.0,11900000.0,0.0,48000.0,-11852000.0,0.0,-11900000.0,0.0,2661000.0,-9184000.0,0.0,0.0,-9184000.0,0.0,-2.8,-2.8,3377434.0,3377434.0,https://www.sec.gov/Archives/edgar/data/1611747/000121390017004338/f20f2016_biondvaxpharma.htm,https://www.sec.gov/Archives/edgar/data/1611747/000121390017004338/f20f2016_biondvaxpharma.htm,1620589783,15:49:43,20210509
4,2015-12-31,BVXV,ILS,2016-04-27,2016-04-27,FY,0.0,0.0,0.0,0.0,7906000.0,3264000.0,0.0,0.0,11303000.0,11303000.0,0.0,133000.0,-11170000.0,0.0,-11303000.0,0.0,1093000.0,-10199000.0,0.0,0.0,-10199000.0,0.0,-4.0,-4.0,2638066.0,2638066.0,https://www.sec.gov/Archives/edgar/data/1611747/000121390016012814/f20f2015_biondvaxpharma.htm,https://www.sec.gov/Archives/edgar/data/1611747/000121390016012814/f20f2015_biondvaxpharma.htm,1620589783,15:49:43,20210509
5,2014-12-31,BVXV,ILS,2014-12-31,2014-12-31,FY,0.0,0.0,0.0,0.0,5492000.0,2650000.0,0.0,0.0,8142000.0,8142000.0,0.0,677000.0,-7465000.0,0.0,-8142000.0,0.0,378000.0,-7764000.0,0.0,0.0,-7764000.0,0.0,-2.4,-2.4,3267434.0,3267434.0,,,1620589783,15:49:43,20210509
6,2013-12-31,BVXV,ILS,2013-12-31,2013-12-31,FY,0.0,0.0,0.0,0.0,5451000.0,0.0,0.0,0.0,0.0,7641000.0,0.0,709000.0,-6932000.0,0.0,-7641000.0,0.0,-395000.0,-8036000.0,0.0,0.0,-8036000.0,0.0,-2.459422,-2.459422,3267434.0,3267434.0,,,1620589783,15:49:43,20210509
7,2012-12-31,BVXV,ILS,2012-12-31,2012-12-31,FY,0.0,0.0,0.0,0.0,6777000.0,0.0,0.0,0.0,0.0,9134000.0,0.0,731000.0,-8403000.0,0.0,-9134000.0,0.0,-197000.0,-9331000.0,0.0,0.0,-9331000.0,0.0,-2.855758,-2.855758,3267434.0,3267434.0,,,1620589783,15:49:43,20210509
8,2011-12-31,BVXV,ILS,2011-12-31,2011-12-31,FY,0.0,0.0,0.0,0.0,5951000.0,0.0,0.0,0.0,0.0,8224000.0,0.0,600000.0,-7624000.0,0.0,-8224000.0,0.0,0.0,-7716000.0,0.0,0.0,-7716000.0,0.0,-2.361486,-2.361486,3267434.0,3267434.0,,,1620589783,15:49:43,20210509
